alsonex.com.au
News
Alsonex
New approach to treating Neurodegenerative Disease
Alsonex is a drug development company dedicated to developing new treatments for many different kinds of neurodegenerative diseases. The company was founded in 2014 and works hard to maintain a culture of excellence in everything that it does. New treatments are urgently required to help slow the progression of neurodegenerative disease and it remains an area of intensive research within the pharmaceutical industry. Many clinical trials are in progress and from this endeavour our expectation is that in coming years neurodegenerative diseases will become a manageable condition. Ultimately, rapid diagnosis followed by quick access to treatments will slow the disease and improve quality of life for sufferers. New research is increasing our understanding of the factors that drive disease progression and that will lead to new treatment options for the more common neurodegenerative diseases such as Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease and Motor Neuron Disease.
News
The search for a viable treatment for MND is an area of intensive research and there are many new developments constantly happening around the world. We keep up to date with all the latest developments from this field and are eager to share information with the public. We post news not only from us but also from other researchers active in the area. Please read on if you’re interested in some news articles detailing the latest developments from this area of important research:
If you would like any further information regarding our research, then please don't hesitate to contact us. Our knowledgeable and friendly team will be more than happy to answer any of the questions that you might have. We welcome media enquiries. Through our research, we hope to make an impact on neurodegenerative disease and although our first interest is in MND, we have an expanding interest in Parkinson's Disease and Alzheimer's Disease.